J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 87 (2006), 3649-3653; DOI 10.1099/vir.0.82261-0

IMMEDIATE OPEN ACCESS ARTICLE
This Article
Free via Open Access: OA
Right arrow OA Free Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hagmaier, K.
Right arrow Articles by Randall, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hagmaier, K.
Right arrow Articles by Randall, R.
Agricola
Right arrow Articles by Hagmaier, K.
Right arrow Articles by Randall, R.
© 2006 Society for General Microbiology

Short Communication

A single amino acid substitution in the V protein of Nipah virus alters its ability to block interferon signalling in cells from different species

Kathrin Hagmaier1, Nicola Stock1,{dagger}, Steve Goodbourn2, Lin-Fa Wang3 and Richard Randall1

1 Centre for Biomolecular Sciences, University of St Andrews, The North Haugh, St Andrews KY16 9ST, UK
2 Division of Basic Medical Sciences, St George's, University of London, London SW17 0RE, UK
3 CSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong, VIC 3220, Australia

Correspondence
Richard Randall
rer{at}st-andrews.ac.uk

The V protein of the paramyxovirus Nipah virus (NiV) has been shown to antagonize the interferon (IFN) response in human cells via sequestration of STAT1 and STAT2. This study describes a mutant of the NiV V protein, referred to as V(AAHL), that is unable to antagonize IFN signalling and demonstrates that a single amino acid substitution is responsible for its inactivity. The molecular basis for this was identified as a failure to interact with STAT1 and STAT2. It was also shown that NiV V, but not V(AAHL), was functional as an IFN antagonist in human, monkey, rabbit, dog, horse, pig and bat cells, which suggests that the ability of NiV to block IFN signalling is not a major constraint that prevents this virus from crossing species barriers.

{dagger}Present address: Howard Hughes Medical Institute, Northwestern University, Evanston, IL 60208-3500, USA.




This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
K. Hagmaier, N. Stock, B. Precious, K. Childs, L.-F. Wang, S. Goodbourn, and R. E. Randall
Mapuera virus, a rubulavirus that inhibits interferon signalling in a wide variety of mammalian cells without degrading STATs
J. Gen. Virol., March 1, 2007; 88(3): 956 - 966.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2006 by the Society for General Microbiology.